AZ8010

News alerts, weekly reports and conference planners

Company:

AstraZeneca, Baylor College of Medicine

Drug class:

FGFR inhibitor

Related drugs:

NRAS G13N	Multiple Myeloma	NRAS G13N	Multiple Myeloma	AZ8010 Resistant: D – Preclinical AZ8010 Resistant : D	AZ8010 Resistant: D – Preclinical AZ8010 Resistant : D
FGFR3 S249C	Urothelial Cancer	FGFR3 S249C	Urothelial Cancer	AZ8010 Sensitive: D – Preclinical AZ8010 Sensitive : D	AZ8010 Sensitive: D – Preclinical AZ8010 Sensitive : D

Associations
(2)